Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 90

1.

Postmenopause as a key factor in the composition of the Endometrial Cancer Microbiome (ECbiome).

Walsh DM, Hokenstad AN, Chen J, Sung J, Jenkins GD, Chia N, Nelson H, Mariani A, Walther-Antonio MRS.

Sci Rep. 2019 Dec 16;9(1):19213. doi: 10.1038/s41598-019-55720-8.

2.

Gut microbiome meta-analysis reveals dysbiosis is independent of body mass index in predicting risk of obesity-associated CRC.

Greathouse KL, White JR, Padgett RN, Perrotta BG, Jenkins GD, Chia N, Chen J.

BMJ Open Gastroenterol. 2019 Feb 28;6(1):e000247. doi: 10.1136/bmjgast-2018-000247. eCollection 2019.

3.

Genome-wide analyses as part of the international FTLD-TDP whole-genome sequencing consortium reveals novel disease risk factors and increases support for immune dysfunction in FTLD.

Pottier C, Ren Y, Perkerson RB 3rd, Baker M, Jenkins GD, van Blitterswijk M, DeJesus-Hernandez M, van Rooij JGJ, Murray ME, Christopher E, McDonnell SK, Fogarty Z, Batzler A, Tian S, Vicente CT, Matchett B, Karydas AM, Hsiung GR, Seelaar H, Mol MO, Finger EC, Graff C, Öijerstedt L, Neumann M, Heutink P, Synofzik M, Wilke C, Prudlo J, Rizzu P, Simon-Sanchez J, Edbauer D, Roeber S, Diehl-Schmid J, Evers BM, King A, Mesulam MM, Weintraub S, Geula C, Bieniek KF, Petrucelli L, Ahern GL, Reiman EM, Woodruff BK, Caselli RJ, Huey ED, Farlow MR, Grafman J, Mead S, Grinberg LT, Spina S, Grossman M, Irwin DJ, Lee EB, Suh E, Snowden J, Mann D, Ertekin-Taner N, Uitti RJ, Wszolek ZK, Josephs KA, Parisi JE, Knopman DS, Petersen RC, Hodges JR, Piguet O, Geier EG, Yokoyama JS, Rissman RA, Rogaeva E, Keith J, Zinman L, Tartaglia MC, Cairns NJ, Cruchaga C, Ghetti B, Kofler J, Lopez OL, Beach TG, Arzberger T, Herms J, Honig LS, Vonsattel JP, Halliday GM, Kwok JB, White CL 3rd, Gearing M, Glass J, Rollinson S, Pickering-Brown S, Rohrer JD, Trojanowski JQ, Van Deerlin V, Bigio EH, Troakes C, Al-Sarraj S, Asmann Y, Miller BL, Graff-Radford NR, Boeve BF, Seeley WW, Mackenzie IRA, van Swieten JC, Dickson DW, Biernacka JM, Rademakers R.

Acta Neuropathol. 2019 Jun;137(6):879-899. doi: 10.1007/s00401-019-01962-9. Epub 2019 Feb 9.

PMID:
30739198
4.

Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction Between SLC38A7 and ALPPL2.

Dudenkov TM, Liu D, Cairns J, Devarajan S, Zhuang Y, Ingle JN, Buzdar AU, Robson ME, Kubo M, Batzler A, Barman P, Jenkins GD, Carlson EE, Goetz MP, Northfelt DW, Moreno-Aspitia A, Desta Z, Reid JM, Kalari KR, Wang L, Weinshilboum RM.

Clin Pharmacol Ther. 2019 Jul;106(1):219-227. doi: 10.1002/cpt.1359. Epub 2019 Mar 18.

5.

Association of mitochondrial DNA copy number with self-rated health status.

Takahashi PY, Jenkins GD, Welkie BP, McDonnell SK, Evans JM, Cerhan JR, Olson JE, Thibodeau SN, Cicek MS, Ryu E.

Appl Clin Genet. 2018 Oct 25;11:121-127. doi: 10.2147/TACG.S167640. eCollection 2018.

6.

Sex differences in NSAID-induced perturbation of human intestinal barrier function and microbiota.

Edogawa S, Peters SA, Jenkins GD, Gurunathan SV, Sundt WJ, Johnson S, Lennon RJ, Dyer RB, Camilleri M, Kashyap PC, Farrugia G, Chen J, Singh RJ, Grover M.

FASEB J. 2018 Jun 13:fj201800560R. doi: 10.1096/fj.201800560R. [Epub ahead of print]

7.

Mapping depression rating scale phenotypes onto research domain criteria (RDoC) to inform biological research in mood disorders.

Ahmed AT, Frye MA, Rush AJ, Biernacka JM, Craighead WE, McDonald WM, Bobo WV, Riva-Posse P, Tye SJ, Mayberg HS, Hall-Flavin DK, Skime MK, Jenkins GD, Wang L, Krishnan RR, Weinshilboum RM, Kaddurah-Daouk R, Dunlop BW; Mood Disorders Precision Medicine Consortium (MDPMC).

J Affect Disord. 2018 Oct 1;238:1-7. doi: 10.1016/j.jad.2018.05.005. Epub 2018 May 26.

8.

Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study.

Pottier C, Zhou X, Perkerson RB 3rd, Baker M, Jenkins GD, Serie DJ, Ghidoni R, Benussi L, Binetti G, López de Munain A, Zulaica M, Moreno F, Le Ber I, Pasquier F, Hannequin D, Sánchez-Valle R, Antonell A, Lladó A, Parsons TM, Finch NA, Finger EC, Lippa CF, Huey ED, Neumann M, Heutink P, Synofzik M, Wilke C, Rissman RA, Slawek J, Sitek E, Johannsen P, Nielsen JE, Ren Y, van Blitterswijk M, DeJesus-Hernandez M, Christopher E, Murray ME, Bieniek KF, Evers BM, Ferrari C, Rollinson S, Richardson A, Scarpini E, Fumagalli GG, Padovani A, Hardy J, Momeni P, Ferrari R, Frangipane F, Maletta R, Anfossi M, Gallo M, Petrucelli L, Suh E, Lopez OL, Wong TH, van Rooij JGJ, Seelaar H, Mead S, Caselli RJ, Reiman EM, Noel Sabbagh M, Kjolby M, Nykjaer A, Karydas AM, Boxer AL, Grinberg LT, Grafman J, Spina S, Oblak A, Mesulam MM, Weintraub S, Geula C, Hodges JR, Piguet O, Brooks WS, Irwin DJ, Trojanowski JQ, Lee EB, Josephs KA, Parisi JE, Ertekin-Taner N, Knopman DS, Nacmias B, Piaceri I, Bagnoli S, Sorbi S, Gearing M, Glass J, Beach TG, Black SE, Masellis M, Rogaeva E, Vonsattel JP, Honig LS, Kofler J, Bruni AC, Snowden J, Mann D, Pickering-Brown S, Diehl-Schmid J, Winkelmann J, Galimberti D, Graff C, Öijerstedt L, Troakes C, Al-Sarraj S, Cruchaga C, Cairns NJ, Rohrer JD, Halliday GM, Kwok JB, van Swieten JC, White CL 3rd, Ghetti B, Murell JR, Mackenzie IRA, Hsiung GR, Borroni B, Rossi G, Tagliavini F, Wszolek ZK, Petersen RC, Bigio EH, Grossman M, Van Deerlin VM, Seeley WW, Miller BL, Graff-Radford NR, Boeve BF, Dickson DW, Biernacka JM, Rademakers R.

Lancet Neurol. 2018 Jun;17(6):548-558. doi: 10.1016/S1474-4422(18)30126-1. Epub 2018 Apr 30.

9.

A Genome-Wide Search for Bipolar Disorder Risk Loci Modified by Mitochondrial Genome Variation.

Ryu E, Nassan M, Jenkins GD, Armasu SM, Andreazza A, McElroy SL, Vawter MP, Frye MA, Biernacka JM.

Mol Neuropsychiatry. 2018 Feb;3(3):125-134. doi: 10.1159/000464444. Epub 2017 Oct 28.

10.

Differential roles of ERRFI1 in EGFR and AKT pathway regulation affect cancer proliferation.

Cairns J, Fridley BL, Jenkins GD, Zhuang Y, Yu J, Wang L.

EMBO Rep. 2018 Mar;19(3). pii: e44767. doi: 10.15252/embr.201744767. Epub 2018 Jan 15.

11.

Beta-defensin 1, aryl hydrocarbon receptor and plasma kynurenine in major depressive disorder: metabolomics-informed genomics.

Liu D, Ray B, Neavin DR, Zhang J, Athreya AP, Biernacka JM, Bobo WV, Hall-Flavin DK, Skime MK, Zhu H, Jenkins GD, Batzler A, Kalari KR, Boakye-Agyeman F, Matson WR, Bhasin SS, Mushiroda T, Nakamura Y, Kubo M, Iyer RK, Wang L, Frye MA, Kaddurah-Daouk R, Weinshilboum RM.

Transl Psychiatry. 2018 Jan 10;8(1):10. doi: 10.1038/s41398-017-0056-8.

12.

Combining a nontargeted and targeted metabolomics approach to identify metabolic pathways significantly altered in polycystic ovary syndrome.

Chang AY, Lalia AZ, Jenkins GD, Dutta T, Carter RE, Singh RJ, Nair KS.

Metabolism. 2017 Jun;71:52-63. doi: 10.1016/j.metabol.2017.03.002. Epub 2017 Mar 8.

13.

SLCO1B1 polymorphisms and plasma estrone conjugates in postmenopausal women with ER+ breast cancer: genome-wide association studies of the estrone pathway.

Dudenkov TM, Ingle JN, Buzdar AU, Robson ME, Kubo M, Ibrahim-Zada I, Batzler A, Jenkins GD, Pietrzak TL, Carlson EE, Barman P, Goetz MP, Northfelt DW, Moreno-Aspita A, Williard CV, Kalari KR, Nakamura Y, Wang L, Weinshilboum RM.

Breast Cancer Res Treat. 2017 Jul;164(1):189-199. doi: 10.1007/s10549-017-4243-3. Epub 2017 Apr 20.

14.

Comparison of Whole-Genome Sequencing Methods for Analysis of Three Methicillin-Resistant Staphylococcus aureus Outbreaks.

Cunningham SA, Chia N, Jeraldo PR, Quest DJ, Johnson JA, Boxrud DJ, Taylor AJ, Chen J, Jenkins GD, Drucker TM, Nelson H, Patel R.

J Clin Microbiol. 2017 Jun;55(6):1946-1953. doi: 10.1128/JCM.00029-17. Epub 2017 Apr 12.

15.

Increased risk of hospitalization for ultrarapid metabolizers of cytochrome P450 2D6.

Takahashi PY, Ryu E, Pathak J, Jenkins GD, Batzler A, Hathcock MA, Black JL, Olson JE, Cerhan JR, Bielinski SJ.

Pharmgenomics Pers Med. 2017 Feb 14;10:39-47. doi: 10.2147/PGPM.S114211. eCollection 2017.

16.

Mitochondrial DNA sequence data reveals association of haplogroup U with psychosis in bipolar disorder.

Frye MA, Ryu E, Nassan M, Jenkins GD, Andreazza AC, Evans JM, McElroy SL, Oglesbee D Jr, Highsmith WE, Biernacka JM.

J Psychiatr Res. 2017 Jan;84:221-226. doi: 10.1016/j.jpsychires.2016.09.027. Epub 2016 Sep 30.

PMID:
27770741
17.

A genome wide association study suggests the association of muskelin with early onset bipolar disorder: Implications for a GABAergic epileptogenic neurogenesis model.

Nassan M, Li Q, Croarkin PE, Chen W, Colby CL, Veldic M, McElroy SL, Jenkins GD, Ryu E, Cunningham JM, Leboyer M, Frye MA, Biernacka JM.

J Affect Disord. 2017 Jan 15;208:120-129. doi: 10.1016/j.jad.2016.09.049. Epub 2016 Sep 30.

PMID:
27769005
18.

Leveraging electronic health records to study pleiotropic effects on bipolar disorder and medical comorbidities.

Prieto ML, Ryu E, Jenkins GD, Batzler A, Nassan MM, Cuellar-Barboza AB, Pathak J, McElroy SL, Frye MA, Biernacka JM.

Transl Psychiatry. 2016 Aug 16;6:e870. doi: 10.1038/tp.2016.138.

19.

Accumulating evidence for a role of TCF7L2 variants in bipolar disorder with elevated body mass index.

Cuellar-Barboza AB, Winham SJ, McElroy SL, Geske JR, Jenkins GD, Colby CL, Prieto ML, Ryu E, Cunningham JM, Frye MA, Biernacka JM.

Bipolar Disord. 2016 Mar;18(2):124-35. doi: 10.1111/bdi.12368. Epub 2016 Mar 2.

PMID:
26934194
20.

TSPAN5, ERICH3 and selective serotonin reuptake inhibitors in major depressive disorder: pharmacometabolomics-informed pharmacogenomics.

Gupta M, Neavin D, Liu D, Biernacka J, Hall-Flavin D, Bobo WV, Frye MA, Skime M, Jenkins GD, Batzler A, Kalari K, Matson W, Bhasin SS, Zhu H, Mushiroda T, Nakamura Y, Kubo M, Wang L, Kaddurah-Daouk R, Weinshilboum RM.

Mol Psychiatry. 2016 Dec;21(12):1717-1725. doi: 10.1038/mp.2016.6. Epub 2016 Feb 23.

21.

Feasibility of investigating differential proteomic expression in depression: implications for biomarker development in mood disorders.

Frye MA, Nassan M, Jenkins GD, Kung S, Veldic M, Palmer BA, Feeder SE, Tye SJ, Choi DS, Biernacka JM.

Transl Psychiatry. 2015 Dec 8;5:e689. doi: 10.1038/tp.2015.185.

22.

Modeling X Chromosome Data Using Random Forests: Conquering Sex Bias.

Winham SJ, Jenkins GD, Biernacka JM.

Genet Epidemiol. 2016 Feb;40(2):123-32. doi: 10.1002/gepi.21946. Epub 2015 Dec 7.

23.

Pharmacogenomics of estrogens on changes in carotid artery intima-medial thickness and coronary arterial calcification: Kronos Early Estrogen Prevention Study.

Miller VM, Jenkins GD, Biernacka JM, Heit JA, Huggins GS, Hodis HN, Budoff MJ, Lobo RA, Taylor HS, Manson JE, Black DM, Naftolin F, Harman SM, de Andrade M.

Physiol Genomics. 2016 Jan;48(1):33-41. doi: 10.1152/physiolgenomics.00029.2015. Epub 2015 Oct 27.

24.

Genome-wide association analysis identified splicing single nucleotide polymorphism in CFLAR predictive of triptolide chemo-sensitivity.

Chauhan L, Jenkins GD, Bhise N, Feldberg T, Mitra-Ghosh T, Fridley BL, Lamba JK.

BMC Genomics. 2015 Jun 30;16:483. doi: 10.1186/s12864-015-1614-1.

25.

Circulating atrial natriuretic peptide genetic association study identifies a novel gene cluster associated with stroke in whites.

Pereira NL, Tosakulwong N, Scott CG, Jenkins GD, Prodduturi N, Chai Y, Olson TM, Rodeheffer RJ, Redfield MM, Weinshilboum RM, Burnett JC.

Circ Cardiovasc Genet. 2015 Feb;8(1):141-9. doi: 10.1161/CIRCGENETICS.114.000624. Epub 2014 Dec 1.

26.

Genetic markers associated with abstinence length in alcohol-dependent subjects treated with acamprosate.

Karpyak VM, Biernacka JM, Geske JR, Jenkins GD, Cunningham JM, Rüegg J, Kononenko O, Leontovich AA, Abulseoud OA, Hall-Flavin DK, Loukianova LL, Schneekloth TD, Skime MK, Frank J, Nöthen MM, Rietschel M, Kiefer F, Mann KF, Weinshilboum RM, Frye MA, Choi DS.

Transl Psychiatry. 2014 Oct 7;4:e462. doi: 10.1038/tp.2014.103.

27.

Aromatase inhibitor-associated bone fractures: a case-cohort GWAS and functional genomics.

Liu M, Goss PE, Ingle JN, Kubo M, Furukawa Y, Batzler A, Jenkins GD, Carlson EE, Nakamura Y, Schaid DJ, Chapman JA, Shepherd LE, Ellis MJ, Khosla S, Wang L, Weinshilboum RM.

Mol Endocrinol. 2014 Oct;28(10):1740-51. doi: 10.1210/me.2014-1147. Epub 2014 Aug 22.

28.

Inflammation-related genetic variants predict toxicity following definitive radiotherapy for lung cancer.

Pu X, Wang L, Chang JY, Hildebrandt MA, Ye Y, Lu C, Skinner HD, Niu N, Jenkins GD, Komaki R, Minna JD, Roth JA, Weinshilboum RM, Wu X.

Clin Pharmacol Ther. 2014 Nov;96(5):609-15. doi: 10.1038/clpt.2014.154. Epub 2014 Jul 23.

29.

Integrative gene set analysis: application to platinum pharmacogenomics.

Fridley BL, Abo R, Tan XL, Jenkins GD, Batzler A, Moyer AM, Biernacka JM, Wang L.

OMICS. 2014 Jan;18(1):34-41. doi: 10.1089/omi.2013.0099. Epub 2013 Nov 7.

30.

Soft truncation thresholding for gene set analysis of RNA-seq data: application to a vaccine study.

Fridley BL, Jenkins GD, Grill DE, Kennedy RB, Poland GA, Oberg AL.

Sci Rep. 2013 Oct 9;3:2898. doi: 10.1038/srep02898.

31.

Contribution of FKBP5 genetic variation to gemcitabine treatment and survival in pancreatic adenocarcinoma.

Ellsworth KA, Eckloff BW, Li L, Moon I, Fridley BL, Jenkins GD, Carlson E, Brisbin A, Abo R, Bamlet W, Petersen G, Wieben ED, Wang L.

PLoS One. 2013 Aug 1;8(8):e70216. doi: 10.1371/journal.pone.0070216. Print 2013.

32.

Selective estrogen receptor modulators and pharmacogenomic variation in ZNF423 regulation of BRCA1 expression: individualized breast cancer prevention.

Ingle JN, Liu M, Wickerham DL, Schaid DJ, Wang L, Mushiroda T, Kubo M, Costantino JP, Vogel VG, Paik S, Goetz MP, Ames MM, Jenkins GD, Batzler A, Carlson EE, Flockhart DA, Wolmark N, Nakamura Y, Weinshilboum RM.

Cancer Discov. 2013 Jul;3(7):812-25. doi: 10.1158/2159-8290.CD-13-0038. Epub 2013 Jun 13.

33.

Kernel canonical correlation analysis for assessing gene-gene interactions and application to ovarian cancer.

Larson NB, Jenkins GD, Larson MC, Vierkant RA, Sellers TA, Phelan CM, Schildkraut JM, Sutphen R, Pharoah PP, Gayther SA, Wentzensen N; Ovarian Cancer Association Consortium, Goode EL, Fridley BL.

Eur J Hum Genet. 2014 Jan;22(1):126-31. doi: 10.1038/ejhg.2013.69. Epub 2013 Apr 17.

34.

TSPYL5 SNPs: association with plasma estradiol concentrations and aromatase expression.

Liu M, Ingle JN, Fridley BL, Buzdar AU, Robson ME, Kubo M, Wang L, Batzler A, Jenkins GD, Pietrzak TL, Carlson EE, Goetz MP, Northfelt DW, Perez EA, Williard CV, Schaid DJ, Nakamura Y, Weinshilboum RM.

Mol Endocrinol. 2013 Apr;27(4):657-70. doi: 10.1210/me.2012-1397. Epub 2013 Mar 21.

35.

Two-phase designs to follow-up genome-wide association signals with DNA resequencing studies.

Schaid DJ, Jenkins GD, Ingle JN, Weinshilboum RM.

Genet Epidemiol. 2013 Apr;37(3):229-38. doi: 10.1002/gepi.21708. Epub 2013 Jan 24.

36.

Regression modeling of allele frequencies and testing Hardy Weinberg Equilibrium.

Schaid DJ, Sinnwell JP, Jenkins GD.

Hum Hered. 2012;74(2):71-82. doi: 10.1159/000345846. Epub 2013 Jan 11.

37.

FKBP5 genetic variation: association with selective serotonin reuptake inhibitor treatment outcomes in major depressive disorder.

Ellsworth KA, Moon I, Eckloff BW, Fridley BL, Jenkins GD, Batzler A, Biernacka JM, Abo R, Brisbin A, Ji Y, Hebbring S, Wieben ED, Mrazek DA, Weinshilboum RM, Wang L.

Pharmacogenet Genomics. 2013 Mar;23(3):156-66. doi: 10.1097/FPC.0b013e32835dc133.

38.

Localization of association signal from risk and protective variants in sequencing studies.

Brisbin A, Jenkins GD, Ellsworth KA, Wang L, Fridley BL.

Front Genet. 2012 Sep 6;3:173. doi: 10.3389/fgene.2012.00173. eCollection 2012.

39.

Pharmacogenomics of selective serotonin reuptake inhibitor treatment for major depressive disorder: genome-wide associations and functional genomics.

Ji Y, Biernacka JM, Hebbring S, Chai Y, Jenkins GD, Batzler A, Snyder KA, Drews MS, Desta Z, Flockhart D, Mushiroda T, Kubo M, Nakamura Y, Kamatani N, Schaid D, Weinshilboum RM, Mrazek DA.

Pharmacogenomics J. 2013 Oct;13(5):456-63. doi: 10.1038/tpj.2012.32. Epub 2012 Aug 21.

40.

Identifying the genetic variation of gene expression using gene sets: application of novel gene Set eQTL approach to PharmGKB and KEGG.

Abo R, Jenkins GD, Wang L, Fridley BL.

PLoS One. 2012;7(8):e43301. doi: 10.1371/journal.pone.0043301. Epub 2012 Aug 14.

41.

Human liver methionine cycle: MAT1A and GNMT gene resequencing, functional genomics, and hepatic genotype-phenotype correlation.

Ji Y, Nordgren KK, Chai Y, Hebbring SJ, Jenkins GD, Abo RP, Peng Y, Pelleymounter LL, Moon I, Eckloff BW, Chai X, Zhang J, Fridley BL, Yee VC, Wieben ED, Weinshilboum RM.

Drug Metab Dispos. 2012 Oct;40(10):1984-92. doi: 10.1124/dmd.112.046953. Epub 2012 Jul 17.

42.

Genome-wide gene-set analysis for identification of pathways associated with alcohol dependence.

Biernacka JM, Geske J, Jenkins GD, Colby C, Rider DN, Karpyak VM, Choi DS, Fridley BL.

Int J Neuropsychopharmacol. 2013 Mar;16(2):271-8. doi: 10.1017/S1461145712000375. Epub 2012 May 2.

43.

A Bayesian integrative genomic model for pathway analysis of complex traits.

Fridley BL, Lund S, Jenkins GD, Wang L.

Genet Epidemiol. 2012 May;36(4):352-9. doi: 10.1002/gepi.21628. Epub 2012 Mar 28.

44.

Merging pharmacometabolomics with pharmacogenomics using '1000 Genomes' single-nucleotide polymorphism imputation: selective serotonin reuptake inhibitor response pharmacogenomics.

Abo R, Hebbring S, Ji Y, Zhu H, Zeng ZB, Batzler A, Jenkins GD, Biernacka J, Snyder K, Drews M, Fiehn O, Fridley B, Schaid D, Kamatani N, Nakamura Y, Kubo M, Mushiroda T, Kaddurah-Daouk R, Mrazek DA, Weinshilboum RM.

Pharmacogenet Genomics. 2012 Apr;22(4):247-53. doi: 10.1097/FPC.0b013e32835001c9.

45.

Gene set analysis of survival following ovarian cancer implicates macrolide binding and intracellular signaling genes.

Fridley BL, Jenkins GD, Tsai YY, Song H, Bolton KL, Fenstermacher D, Tyrer J, Ramus SJ, Cunningham JM, Vierkant RA, Chen Z, Chen YA, Iversen E, Menon U, Gentry-Maharaj A, Schildkraut J, Sutphen R, Gayther SA, Hartmann LC, Pharoah PD, Sellers TA, Goode EL.

Cancer Epidemiol Biomarkers Prev. 2012 Mar;21(3):529-36. doi: 10.1158/1055-9965.EPI-11-0741. Epub 2012 Feb 2.

46.

Serine hydroxymethyltransferase 1 and 2: gene sequence variation and functional genomic characterization.

Hebbring SJ, Chai Y, Ji Y, Abo RP, Jenkins GD, Fridley B, Zhang J, Eckloff BW, Wieben ED, Weinshilboum RM.

J Neurochem. 2012 Mar;120(6):881-90. doi: 10.1111/j.1471-4159.2012.07646.x. Epub 2012 Feb 6.

47.

Gemcitabine metabolic pathway genetic polymorphisms and response in patients with non-small cell lung cancer.

Li L, Schaid DJ, Fridley BL, Kalari KR, Jenkins GD, Abo RP, Batzler A, Moon I, Pelleymounter L, Eckloff BW, Wieben ED, Sun Z, Yang P, Wang L.

Pharmacogenet Genomics. 2012 Feb;22(2):105-16. doi: 10.1097/FPC.0b013e32834dd7e2.

48.

Use of the gamma method for self-contained gene-set analysis of SNP data.

Biernacka JM, Jenkins GD, Wang L, Moyer AM, Fridley BL.

Eur J Hum Genet. 2012 May;20(5):565-71. doi: 10.1038/ejhg.2011.236. Epub 2011 Dec 14.

49.

Using the gene ontology to scan multilevel gene sets for associations in genome wide association studies.

Schaid DJ, Sinnwell JP, Jenkins GD, McDonnell SK, Ingle JN, Kubo M, Goss PE, Costantino JP, Wickerham DL, Weinshilboum RM.

Genet Epidemiol. 2012 Jan;36(1):3-16. doi: 10.1002/gepi.20632. Epub 2011 Dec 7.

50.

Gene set analysis of purine and pyrimidine antimetabolites cancer therapies.

Fridley BL, Batzler A, Li L, Li F, Matimba A, Jenkins GD, Ji Y, Wang L, Weinshilboum RM.

Pharmacogenet Genomics. 2011 Nov;21(11):701-12. doi: 10.1097/FPC.0b013e32834a48a9.

Supplemental Content

Loading ...
Support Center